Viventia Biotech Inc.

Viventia Biotech Inc.

  • 10 Four Seasons Place Suite 501 Toronto
  • Etobicoke, Ontario
  • M9B 6H7

Website Links

Description

Viventia Biotech Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of advanced monoclonal antibody products designed to offer safer, more beneficial therapies for those who suffer from cancer. Our lead product candidate Proxinium™ is in multiple clinical studies for the treatment of head and neck cancer. Vicinium™ is currently in an on-going clinical study for the treatment of bladder cancer.

Products & services

Similar companies nearby